Corrigendum to 'Discovery of the first known small-molecule inhibitors of heme-regulated eukaryotic initiation factor 2α (HRI) kinase' [Bioorg. Med. Chem. Lett. 19 (2009) 6548]

Corrigendum Corrigendum to ‘‘Discovery of the first known small-molecule inhibitors of heme-regulated eukaryotic initiation factor 2a (HRI) kinase” [Bioorg. Med. Chem. Lett. 19 (2009) 6548] Mark D. Rosen *, Craig R. Woods, Steven D. Goldberg, Michael D. Hack, A. Dawn Bounds, Young Yang, Pamela C. Wagaman, Victor K. Phuong, Angela P. Ameriks, Terrance D. Barrett, Kimon C. Kanelakis, Jui Chang Chuang, Nigel P. Shankley, Michael H. Rabinowitz Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 3210 Merryfield Row, San Diego, CA 92121, United States